J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 87 (2006), 2243-2251; DOI 10.1099/vir.0.81826-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zahn, A.
Right arrow Articles by Allain, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zahn, A.
Right arrow Articles by Allain, J.-P.
Agricola
Right arrow Articles by Zahn, A.
Right arrow Articles by Allain, J.-P.
© 2006 Society for General Microbiology

Hepatitis C virus interacts with human platelet glycoprotein VI

Astrid Zahn1,2, Nicola Jennings1, Willem H. Ouwehand1,2 and Jean-Pierre Allain1

1 Division of Transfusion Medicine, Department of Haematology, University of Cambridge, Cambridge CB2 2PT, UK
2 National Blood Service, Long Road, Cambridge CB2 2PT, UK

Correspondence
Jean-Pierre Allain
jpa1000{at}cam.ac.uk

Hepatitis C virus (HCV) interacts with human platelets in vivo as a potential transport of infectious virions to the target liver. The binding of native viral particles with the platelet membrane glycoprotein VI (GPVI) was analysed. A consistent interaction between HCV from plasma or after purification by two different methods and the recombinant extracellular immunoglobulin (Ig)-like domains of human GPVI (hD1D2) was observed with two independent experimental approaches: pull-down and ELISA assays. Between 2 and 7 % of HCV particles were specifically bound to hD1D2. The binding was inhibited by an anti-hD1D2 in a dose-dependent manner. Human D1D2 interaction with HCV was significantly higher than the murine D1D2, supporting the specificity of the interaction and to the single human domains (D1 and D2), suggesting that both Ig-like domains of the molecule are required for efficient binding. GPVI may be a platelet surface ligand for HCV playing a role in viral transport and persistence.




This article has been cited by other articles:


Home page
J Electron Microsc (Tokyo)Home page
K. Ghosh, S. Gangodkar, P. Jain, S. Shetty, S. Ramjee, P. Poddar, and A. Basu
Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy
J. Electron Microsc. (Tokyo), June 1, 2008; 57(3): 113 - 118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2006 by the Society for General Microbiology.